
Arvinas has managed to secure another big pharma collaboration, after it announced that Pfizer had signed a research and licensing …

Genentech first signed a deal with Arvinas, a biotech focused on drugs within the protein degradation class, back in 2015. …
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

